Praxis Precision Medicines, Inc. (PRAX)
318.95
-9.18
(-2.80%)
USD |
NASDAQ |
Nov 16, 11:43
Praxis Precision Medicines Enterprise Value : 8.426B for Nov. 13, 2026
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 13, 2026 | 8.426B |
| November 12, 2026 | 8.332B |
| November 11, 2026 | 8.931B |
| November 10, 2026 | 8.690B |
| November 09, 2026 | 8.561B |
| November 06, 2026 | 7.014B |
| November 05, 2026 | 6.594B |
| November 04, 2026 | 7.215B |
| November 03, 2026 | 7.095B |
| November 02, 2026 | 6.913B |
| October 30, 2026 | 7.247B |
| October 29, 2026 | 7.322B |
| October 28, 2026 | 7.234B |
| October 27, 2026 | 6.734B |
| October 26, 2026 | 6.728B |
| October 23, 2026 | 6.325B |
| October 22, 2026 | 6.492B |
| October 21, 2026 | 6.423B |
| October 20, 2026 | 6.647B |
| October 19, 2026 | 6.527B |
| October 16, 2026 | 6.012B |
| October 15, 2026 | 6.193B |
| October 14, 2026 | 5.936B |
| October 13, 2026 | 6.056B |
| October 12, 2026 | 6.281B |
| Date | Value |
|---|---|
| October 09, 2026 | 6.518B |
| October 08, 2026 | 6.621B |
| October 07, 2026 | 7.026B |
| October 06, 2026 | 7.085B |
| October 05, 2026 | 7.180B |
| October 02, 2026 | 7.514B |
| October 01, 2026 | 7.274B |
| September 30, 2026 | 7.395B |
| September 29, 2026 | 7.087B |
| September 28, 2026 | 7.217B |
| September 25, 2026 | 7.081B |
| September 24, 2026 | 7.109B |
| September 23, 2026 | 7.118B |
| September 22, 2026 | 7.636B |
| September 21, 2026 | 7.586B |
| September 18, 2026 | 7.588B |
| September 17, 2026 | 7.910B |
| September 16, 2026 | 7.868B |
| September 15, 2026 | 7.978B |
| September 14, 2026 | 8.470B |
| September 11, 2026 | 8.583B |
| September 10, 2026 | 8.694B |
| September 09, 2026 | 8.882B |
| September 08, 2026 | 9.083B |
| September 04, 2026 | 9.064B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| BioMarin Pharmaceutical, Inc. | 14.55B |
| Ironwood Pharmaceuticals, Inc. | 1.049B |
| Xencor, Inc. | 2.528B |
| IDEAYA Biosciences, Inc. | 2.268B |
| ACADIA Pharmaceuticals, Inc. | 2.335B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -94.23M |
| Total Expenses (Quarterly) | 94.23M |
| EPS Diluted (Quarterly) | -3.230 |
| Earnings Yield | -4.02% |
| Normalized Earnings Yield | -4.016 |